glp-1 impulse control therapy appears to reduce binge eating type behaviours in people with obesity, based upon this recently published systematic review and meta-analysis eClinicalMedicine, 2026, 104007, ISSN 2589-5370 GLP-1 Agonists: A Breakthrough in

DPP4 and SLE (Systemic Lupus Erythematosus) Many individuals diagnosed with systemic lupus erythematosus (SLE), a chronic autoimmune disease affecting multiple organ systems, develop a characteristic butterfly rash

When pharmacies consistently can't obtain the FDA-approved drug in quantities they need to meet patient demand, that drug is not commercially available the very definition of a shortage. Here are five questions answered about the FDA's decision to halt compounded versions of GLP-1 drugs

So when the drugs are then taken away, you havent got those sort of behavioural strategies in place that help keep the weight off. Responding to the findings, Tam Fry, the chair of the National Obesity Forum, said: It shouldnt surprise anyone if people regain weight having used GLP-1 drugs without seriously attempting to improve their lifestyle Using GLP-1 is not the quick fix which many users believe it to be. Jane Ogden, a professor of health psychology at Surrey University, said there was no point just throwing people back out into the world of their own lives, carrying on their own behaviours from before after coming off the injections

Sleep: Persistent itching can also affect sleep quality, leading to fatigue and decreased productivity

Importantly, insulin should never be stopped abruptly